Objectives: We performed the long-term follow-up of a large cohort of patients in a multicenter study receiving left main coronary artery (LMCA) revascularization. Background: Limited information is available on long-term outcomes for patients with unprotected LMCA disease who underwent coronary stent procedure or coronary artery bypass grafting (CABG). Methods: We evaluated 2,240 patients with unprotected LMCA disease who received coronary stents (n = 1,102; 318 with bare-metal stents and 784 with drug-eluting stents) or underwent CABG (n = 1,138) between 2000 and 2006 and for whom complete follow-up data were available for at least 3 to 9 years (median 5.2 years). The 5-year adverse outcomes (death; a composite outcome of death, Q-wave myocardial infarction [MI], or stroke; and target vessel revascularization [TVR]) were compared with the use of the inverse probability of treatment weighted method and propensity-score matching. Results: After adjustment for differences in baseline risk factors with the inverse probability of treatment weighting, the 5-year risk of death (hazard ratio [HR]: 1.13; 95% confidence interval [CI]: 0.88 to 1.44, p = 0.35) and the combined risk of death, Q-wave MI, or stroke (HR: 1.07; 95% CI: 0.84 to 1.37, p = 0.59) were not significantly different for patients undergoing stenting versus CABG. The risk of TVR was significantly higher in the stenting group than in the CABG group (HR: 5.11; 95% CI: 3.52 to 7.42, p < 0.001). Similar results were obtained in comparisons of bare-metal stent with concurrent CABG and of drug-eluting stent with concurrent CABG. In further analysis with propensity-score matching, overall findings were consistent. Conclusions: During 5-year follow-up, stenting showed similar rates of mortality and of the composite of death, Q-wave MI, or stroke but higher rates of TVR as compared with CABG for patients with unprotected LMCA disease.
|Number of pages||8|
|Journal||Journal of the American College of Cardiology|
|Publication status||Published - 2010 Jul 6|
Bibliographical noteFunding Information:
Dr. Duk-Woo Park has received lecture fees from Cordis and Boston Scientific. Dr. Young-Hak Kim has received lecture fees from Cordis. Dr. Cheol Whan Lee has received lecture fees from Medtronic. Dr. Seng-Wook Park has received research support from Medtronic . Dr. Hyeon-Cheol Gwon has received lecture fees from Boston Scientific and Medtronic, and research grant support from Medtronic . Dr. Myung-Ho Jeong has received lecture fees from Cordis, Medtronic, and Boston Scientific. Dr. Hyo-Soo Kim has received consulting fees from Abbott Vascular. Dr. In-Whan Seong has received grant support from Boston Scientific . Dr. Seung-Jea Tahk has received lecture fees from Boston Scientific. Dr. Wook-Song Chung has received lecture fees from Cordis and Boston Scientific. Dr. Seung-Jung Park has received consulting fees from Cordis, lecture fees from Cordis, Medtronic, and Boston Scientific, and received research grant from Cordis and Medtronic .
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine